Healthcare companies that are in the process of developing a vaccine are already getting significant investor attention and their stocks could skyrocket with the arrival of their vaccine candidate in the market. Johnson & Johnson (JNJ), Merck (MRK) and Novo Nordisk (NVO) are the top picks on that front.